Drug Shortage Report for 5% DEXTROSE INJECTION
| Report ID | 106782 |
| Drug Identification Number | 02403536 |
| Brand name | DEXTROSE 5% INJECTION |
| Common or Proper name | Dextrose |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 50mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-14 |
| Estimated end date | 2020-03-10 |
| Actual end date | 2020-03-04 |
| Shortage status | Resolved |
| Updated date | 2020-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-03-05 | French | Compare |
| v3 | 2020-03-05 | English | Compare |
| v2 | 2020-02-20 | French | Compare |
| v1 | 2020-02-20 | English | Compare |
Showing 1 to 4 of 4